iTonic Holdings (ITOC) Long-Term Deferred Tax (2023)

iTonic Holdings (ITOC) reported Long-Term Deferred Tax of $22124.0 for Q4 2023.

iTonic Holdings (ITOC) Long-Term Deferred Tax (2023) Analysis & Trends

iTonic Holdings (ITOC) has 1 years of Long-Term Deferred Tax data on file, last reported at $22124.0 in Q4 2023.

For the quarter ending Q4 2023, Long-Term Deferred Tax changed N/A year-over-year to $22124.0; the trailing twelve-month figure through Dec 2023 stood at $22124.0 (changed N/A YoY), and the FY2023 full-year result was $22124.0, changed N/A from the prior year.
Long-Term Deferred Tax was little changed at $22124.0 in Q4 2023.
In the past five years, Long-Term Deferred Tax ranged from a high of $22124.0 in Q4 2023 to a low of $22124.0 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn
10	iTonic Holdings	3.87 Mn	942,190.16	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	22,124.00